Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

1. Grande, E.
2. Arranz, J.Á.
3. De Santis, M.
4. Bamias, A.
5. Kikuchi, E.
6. del Muro, X.G.
7. Park, S.H.
8. De Giorgi, U.
9. Alekseev, B.
10. Mencinger, M.
11. Izumi, K.
12. Schutz, F.A.
13. Puente, J.
14. Li, J.-R.
15. O'Donnell, P.H.
16. Kalebasty, A.R.
17. Ye, D.
18. Mariathasan, S.
19. Bene-Tchaleu, F.
20. Bernhard, S.
21. Lee, C.
22. Davis, I.D.
23. Galsky, M.D.